Xcout IntelOruka Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Oruka Therapeutics, Inc. among healthcare companies — ranked by similarity to what Oruka Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Oruka Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc. is a biopharmaceutical company dedicated to developing novel biologics designed to establish a new treatment standard for chronic skin diseases.
Oruka Therapeutics, Inc. at a glance
Oruka Therapeutics, Inc. is a healthcare company headquartered in Menlo Park, United States. It is publicly listed (ORKA) with a market capitalisation of $5.1B. Xcout tracks 24 named people at Oruka Therapeutics, Inc., including Lawrence Otto Klein (President, Chief Executive Officer & Director).
Oruka Therapeutics, Inc. leadership
- Lawrence Otto KleinPresident, Chief Executive Officer & Director
- Lawrence KleinChief Executive Officer
- Laura SandlerChief Operating Officer
- Joana GoncalvesChief Medical Officer
- Larry Todd EdwardsChief Commercial Officer
- Paul QuinlanGeneral Counsel
18 more named people on record for Oruka Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Top 12 Oruka Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Oruka Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar healthcare company
Nuvig Therapeutics, Inc. is a company headquartered in Palo Alto, California, dedicated to developing novel immune and therapeutic treatments for chronic autoimmune diseases.
Similar healthcare company
SolasCure Limited is a biotechnology research company registered and headquartered in Cambridge, United Kingdom, focused on developing novel wound care solutions.
Similar healthcare company
Ausperbio is a clinical-stage biopharmaceutical company dedicated to transforming hepatitis B virus (HBV) treatment for a cure and advancing oligonucleotide therapeutics.
Similar healthcare company
Elevar Therapeutics is a fully integrated biopharmaceutical company founded in 2019 that focuses on elevating treatment experiences and patient outcomes.
Biotechnology
Aldena Therapeutics is a biotechnology company focused on transforming dermatology through novel siRNA-based treatments for skin conditions.
Biotechnology
Rinascera Therapeutics, Inc. is a clinical-stage biotechnology company located in Boston, Massachusetts, dedicated to transforming the treatment of rare genetic skin diseases.
Biotechnology & Pharmaceuticals
Kalm Therapeutics, Inc. is a pre-clinical drug development company founded in 2024 and focused on pioneering a breakthrough treatment for eczema.
Biotechnology
Palvella Therapeutics is a biotechnology company headquartered in Wayne, Pennsylvania, that specializes in developing and commercializing medicines for patients with rare dermatological diseases. The publicly traded company operates with corporate offices and an active team dedicated to clinical and commercial development.
Biotechnology
Arcutis Biotherapeutics is a biotechnology company focused on medical dermatology innovation. The company is publicly traded and dedicated to delivering meaningful treatments in the dermatology field.
Biotechnology
Villaris Therapeutics was a clinical-stage biotechnology company developing antibody-based therapies for autoimmune and inflammatory skin diseases. Its intended beneficiaries were patients with immune-mediated dermatologic conditions.
Biotech
A clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases using its ATTOBODY biologics platform. The company's lead candidate, ATTO-1310, targets interleukin-31 (IL-31), known as the 'itch cytokine,' for the treatment of chronic pruritic diseases including atopic dermatitis. Its pipeline also includes multi-specific candidates for other inflammatory diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Oruka Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Oruka Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →